Evidence map›Paper›PMID 39258225›Full record

ArticleLeukemia research reports2024

Acute myeloid leukemia with a

Hidetsugu Kawai, Sawako Shiraiwa, Daisuke Ogiya, Masako Toyosaki, Shinichiro Machida, Rikio Suzuki, Makoto Onizuka, Yoshiaki Ogawa, Hiroshi Kawada

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia research reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hidetsugu KawaiDepartment of Hematology / Oncology, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Sawako ShiraiwaDepartment of Hematology / Oncology, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Daisuke OgiyaDepartment of Hematology / Oncology, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Masako ToyosakiDepartment of Hematology / Oncology, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Shinichiro MachidaDepartment of Hematology / Oncology, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Rikio SuzukiDepartment of Hematology / Oncology, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Makoto OnizukaDepartment of Hematology / Oncology, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Yoshiaki OgawaDepartment of Hematology / Oncology, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Hiroshi KawadaDepartment of Hematology / Oncology, Tokai University School of Medicine, Isehara, Kanagawa, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The t(10;17)(p15;q21) translocation is a very rare recurrent cytogenetic aberration, and produced

Indexed as

Leukemia after chemotherapy and radiotherapy in patients of breast cancerZMYND11-MBTD1 fusion gene

Identifiers

PMID39258225
PMCPMC11385777

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.